Skip to content

CLARIFLEX CLRFLXC (REF CLRFLXC155)Recalls & reported problems

Johnson & Johnson Surgical Vision, Inc. · SIL 13.0MM 6 OPT MOD C PMMA OPTIEDGE II · Class 3 · Implant

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 05050474501461), received between Apr 27, 2023 and Apr 27, 2023 — classified as 1 injury.

The most frequently reported specific device problem is “Material Discolored” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Material Discolored1

Patient problems

  • Blurred Vision1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryApr 27, 2023Material Discolored; Material Discolored

    IT WAS REPORTED THAT THE INTRAOCULAR LENS (IOL) WAS EXPLANTED FROM THE PATIENT'S EYE DUE TO BLURRY VISION AS A RESULT OF THE IOL BEING CLOUDY. THE PATIENT'S REPORTED VISUAL ACUITY WAS 1.2. POSTOPERATIVELY, THE PATIENT'S VISION WAS STATED AS BEING GOOD WITH NO PROBLEMS. SUTURES WERE REQUIRED, BUT THERE WAS NO REPORTED HEALTH DAMAGE AFTER SURGERY. THE REPLACEMENT IOL MODEL IS UNKNOWN. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: Blurred Vision

    MAUDE report 16828089 ↗

Other intraocular lens devices

All intraocular lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page